Golimumab, 50 mg/0.5 mL injection, 1x 0.5 mL, syringe Simponi®;

Infliximab, 100 mg injection, 1x 100 mg vial, Remicade®;

Ustekinumab 45 mg/0.5 ml injection, 1x 0.5 ml vial, Stelara®; Janssen-Cilag Pty Ltd

• Public Summary Document (PSD) July 2014 PBAC Meeting - (PDF 157 KB)
• Public Summary Document (PSD) July 2014 PBAC Meeting - (Word 177 KB)